Ospemifene in the Management of Vulvar and Vaginal Atrophy: Focus on the Assessment of Patient Acceptability and Ease of Use
Angelo Cagnacci, 1 Anjeza Xholli, 2 Martina Venier 2 1Obstetrics and Gynaecology Unit, Obstetrics and Gynaecology University of Genova, Genova, Italy; 2Obstetrics and Gynaecology Unit, Azienda Sanitaria Universitaria Integrata di Udine, Udine, ItalyCorrespondence: Angelo CagnacciGinecologia e Oste...
Main Authors: | Cagnacci A, Xholli A, Venier M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-01-01
|
Series: | Patient Preference and Adherence |
Subjects: | |
Online Access: | https://www.dovepress.com/ospemifene-in-the-management-of-vulvar-and-vaginal-atrophy-focus-on-th-peer-reviewed-article-PPA |
Similar Items
-
Ospemifene for vulvar and vaginal atrophy: an overview
by: Santiago Palacios
Published: (2020-07-01) -
Experience with ospemifene in patients with vulvar and vaginal atrophy and associated sexual dysfunction: case studies
by: Ana Rosa Jurado López, et al.
Published: (2020-07-01) -
Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause
by: Wurz GT, et al.
Published: (2014-11-01) -
Experience with ospemifene in patients with vulvar and vaginal atrophy and a history of breast cancer: case studies
by: Mariella Lilue, et al.
Published: (2020-07-01) -
Experience with ospemifene in patients with vulvar and vaginal atrophy and urinary incontinence: case studies
by: Zuramis Estrada Blanco, et al.
Published: (2020-07-01)